Keith A. Johnson
Grants and prizes
P01, Impact of Amyloid and Tau on the Aging Brain: The Harvard Aging Brain Study, P01AG036694, 2010–2031, 28 Aug 2026
R01, The Ante-Amyloid Treatment of Alzheimer's disease (A3) Trial and Alzheimer Plasma EXtension (APEX) Study, R01AG095009, 2025–2030, 19 Aug 2026
R01, Multi-biomarker evaluation of 64Cu-FBP8 PET for imaging of brain fibrin in aging and neurodegeneration, R01AG093756, 2026–2029, 17 Feb 2026
R13, Human Amyloid Imaging (HAI) Meeting, R13AG042201, 2012–2030, 9 Jan 2026
R01, API A4 Alzheimer's Prevention Trial, R01AG058468, 2018–2025, 11 Mar 2025
R01, The Alzheimer's Disease Tau Platform Clinical Trial, R01AG078457, 2023–2030, 28 Aug 2024
R01, Combination anti-amyloid therapy for preclinical Alzheimer's disease, R01AG061848, 2018–2025, 10 Jul 2024
R01, The A3 Study: Ante-Amyloid Prevention of Alzheimer's disease, R01AG054029, 2016–2024, 16 Jun 2023
Sources: reporter.nih.gov